Observations placeholder

Cognex

Identifier

018218

Type of Spiritual Experience

Hallucination

Number of hallucinations: 44

Background

A description of the experience

Tacrine is a centrally acting anticholinesterase and indirect cholinergic agonist (parasympathomimetic). It was the first centrally acting cholinesterase inhibitor approved for the treatment of Alzheimer's disease, and was marketed under the trade name Cognex.  It also acts as a histamine N-methyltransferase inhibitor

On Oct, 20, 2015: 733 people reported to have side effects when taking Cognex. Among them, 44 people (6.00%) have Hallucination.

 

On Sep, 30, 2015: 733 people reported to have side effects when taking Cognex. Among them, 3 people (0.41%) have Death.

 

The source of the experience

eHealthme

Concepts, symbols and science items

Concepts

Symbols

Science Items

Activities and commonsteps

Commonsteps

References